Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (2254)	9/19/2014 12:17:45 AM
From: Clarksterh	of 2344

<<I haven't seen it once, much less repeatedly.>> Well now, with the Japanese trial you've seen it once -g- BTW - biomaven recently asked in iHub if anyone on that board had ever seen a failed ph iii with a post hoc that was successful on repeat in the post hoc group. Silence was the answer. On that board that means something. (I think I remember one but it is rare. Successful post hocs are a dime a dozen. As Fleming says, any scientist (or CEO) can find one. But they rarely repeat because they not real. They are an artifact of human nature (confirmation bias) not reality.)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next